Fremanezumab in Children and Adolescents with Episodic Migraine - Part 1
In part one of this two-part series, Dr. Tesha Monteith and Dr. Andrew Hershey summarize findings from the SPACE trial evaluating fremanezumab in adolescents and children with migraine. Show…
Read the full articleYou might also wanna read
CGRP monoclonal antibody fremanezumab may reduce weather-triggered migraine attacks, study finds
Preventive treatment may blunt the impact of weather-related migraine triggers, in what investigators say is a first for migraine prevention
mdsc.pe·21d agoIntranasal Zavegepant for the acute treatment of migraine in adults: A review of randomized clinical trials
Migraine is a highly prevalent chronic neurological disorder and one of the leading causes of disability worldwide. Among recent therapeutic
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this re-released episode of CME on the Go, originally published on 12/1/2025, our hosts discuss the complexities of diagnosing and treati
Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom
Conditions : Migraine Sponsors : AbbVie Not yet recruiting
CME | Stimulants & Strategy: Integrating ADHD Treatments Into Daily Practice
In this episode of CME on the go, recorded live at FMX in Anaheim, our hosts discuss the complexities of ADHD treatment. They cover initial
CME | This Is Giving Me a Headache: Managing the Headache Patient Without Losing Your Mind
In this episode of CME on the Go, our hosts discuss the complexities of diagnosing and treating headaches in primary care. They cover common
Comments
Sign in to join the conversation.
No comments yet. Be the first.